SB 6086 Washington Senate · 2019-2020 Regular Session

Increasing access to medications for opioid use disorder.

Bill status signed all 5 stages cleared

Introduction

Dec 2019

Committee Review

Feb 2020

Senate Passage

Mar 2020

House Passage

Mar 2020

Signed into Law

Mar 2020

Introduced Dec 18, 2019 Signed Mar 31, 2020

Floor votes · Senate Feb 14, 2020 · House Mar 6, 2020

How they voted

42–0

Passed · 2 other

Total votes 44

Feb 14, 2020

D Democratic27

27 Yea

100% Yea

R Republican17

15 Yea 2

88% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Mar 31, 2020

Signed into law

Governor signed.

upper

Mar 10, 2020

Upper · Passed

Speaker signed.

upper

Mar 9, 2020

Upper · Passed

President signed.

upper

Mar 6, 2020

House · Passed

House Vote: pass (93-0-1)

house

Feb 25, 2020

Committee

Referred to Rules 2 Review.

upper

Feb 21, 2020

Lower · Passed

Scheduled for public hearing in the House Committee on Health Care & Wellness at 08:30 AM

lower

Feb 21, 2020

Upper · Passed

HCW - Majority; do pass.

upper

Feb 20, 2020

Lower · Passed

Scheduled for public hearing in the House Committee on Health Care & Wellness at 10:00 AM

lower

Feb 14, 2020

Senate · Passed

Senate Vote: pass (42-0-2)

senate

Jan 31, 2020

Upper · Passed

Scheduled for public hearing in the Senate Committee on Behavioral Health Subcommittee to Health & Long Term Care at 01:30 PM

upper

Jan 31, 2020

Upper · Passed

BH - Majority; 1st substitute bill be substituted, do pass.

upper

Jan 24, 2020

Upper · Passed

Scheduled for public hearing in the Senate Committee on Behavioral Health Subcommittee to Health & Long Term Care at 01:30 PM

upper

Jan 13, 2020

Upper · Passed

Scheduled for public hearing in the Senate Committee on Health & Long Term Care at 02:30 PM

upper

Jan 13, 2020

Committee

Referred to Behavioral Health Subcommittee to Health & Long Term Care.

upper

1 primary · 3 co-sponsors